Clinical trial to study the effects of two drugs cisatracurium and rocuronium in paediatric patients undergoing routine surgeries under general anaesthesia

A Comparative study to evaluate the efficacy of cisatracurium and rocuronium for endotracheal intubation in paediatric Patients : A prospective randomized study - Nil

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/02/062258

Enrollment

Registered

2024-02-05

Start date

Unknown

Completion date

Unknown

Last updated

2024-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J989- Respiratory disorder, unspecified

Interventions

Control Intervention1: cisatracurium: cisatracurium 0.15mg/kg given intravenously ,endotracheal intubation was done after 3 minutes of drug administration in paediatric patients undergoing elective su

Eligibility

Inclusion criteria

Inclusion criteria: patients undergoing elective surgical procedures under general anaesthesia between 2 to 12 years of age and between 10 kg to 40 kg body weight

Exclusion criteria

Exclusion criteria: patients refusal,ASA grade 3 and 4 ,age below 2 years and above 12 years,weight below 10 kg and above 40 kg,patient with disorders of cardiovascular,hepatic,renal or neuromuscular system and epilepsy,pt with airway problems suggestive of difficult intubation,patients with know history of drug allergy

Design outcomes

Primary

Measure	Time frame
rocuronium has rapid onset and produces excellent to good intubating conditions than cisatracuriumTimepoint: 24 hours	—

Secondary

Measure	Time frame
no adverse effects noted with both cisatracurium and rocuroniumTimepoint: 24 hours	—

Countries

India

Contacts

Public ContactDr R. Deepak

Gajra raja medical College

drseema26@gmail.com7566439701

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026